Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test - Lawn, Stephen D; Mwaba, Peter; Bates, Matthew; Piatek, Amy; Alexander, Heather; Marais, Ben J; Cuevas, Luis E; McHugh, Timothy D; Zijenah, Lynn; Kapata, Nathan; Abubakar, Ibrahim; McNerney, Ruth; et al. (The Lancet infectious diseases, 2013)
Keywords: AIDS-Related Opportunistic Infections - diagnosis; AIDS-Related Opportunistic Infections - microbiology; Antibiotics, Antitubercular; Bacterial diseases; Biological and medical sciences; Cost of Illness; Cost-Benefit Analysis; Drug Resistance, Bacterial; Global Health; Health Care Costs; Human bacterial diseases; Human immunodeficiency virus; Humans; Infectious Disease; Infectious diseases; Medical sciences; Mycobacterium tuberculosis; Mycobacterium tuberculosis - drug effects; Mycobacterium tuberculosis - genetics; Mycobacterium tuberculosis - isolation & purification; Nucleic Acid Amplification Techniques; Point-of-Care Systems - trends; Predictive Value of Tests; Rifampin; Sputum - microbiology; Tuberculosis; Tuberculosis and atypical mycobacterial infections; Tuberculosis, Multidrug-Resistant - diagnosis; Tuberculosis, Multidrug-Resistant - drug therapy; Tuberculosis, Multidrug-Resistant - epidemiology; Tuberculosis, Multidrug-Resistant - mortality; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - epidemiology; Infection; Bacteriosis; Tuberculosis; Mycobacterial infection; Diagnosis